tDCS and Symptom Provocation in Treatment-Resistant OCD
Key facts
- Who runs it
- Centre Hospitalier Henri Laborit
- Where
- France6 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- People taking part
- 178 people, planned
- Starts
- 1 Dec 2026
- Expected to end
- 15 Oct 2029
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- tDCS session
- symptom provocation
- Record updated
- 21 October 2026
Who can take part
- Age
- 18 years to 70 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 20 criteriaShow less
Who can take part
- Diagnosis of Obsessive-Compulsive Disorder (OCD) according to DSM-5, with a duration ≥ 2 years
- Good insight, defined as a BABS score ≤ 18
- Chronic OCD, with either a Y-BOCS total score > 20 or a subscale score > 15
- Treatment-resistant OCD, defined as:; failure of ≥ two adequate trials of SSRIs, or; failure of one SSRI plus augmentation with an atypical antipsychotic,
- and/or insufficient response after ≥ one year of cognitive-behavioural therapy
- Stable pharmacological treatment (fixed antidepressant dose) for at least 12 weeks prior to inclusion, with no significant improvement during this period
- Age 18 to 70 years
- Ability to provide informed written consent
- Affiliation with the French social security system
Who cannot take part
- Compulsory psychiatric hospitalisation
- Current DSM-5 Axis I disorder other than OCD (schizophrenia spectrum, bipolar disorder, substance use)
- History of traumatic brain injury
- Presence of intracranial metal, pacemaker, or epilepsy
- Women of childbearing potential without effective contraception, or those unwilling to maintain abstinence or contraception
- Pregnancy or breastfeeding
- Legal guardianship or curatorship
- Current major depressive episode (MADRS > 21)
- Suicide risk (MADRS item 10 > 3)
- Dermatological lesions at electrode placement sites
- Emergency situations or inability to provide informed consent
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 70 years old?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this clinical trial is to learn if symptom provocation before transcranial Direct Current Stimulation (tDCS) in Obsessive-Compulsive Disorder (OCD) patients. The main question it aims to answer is:
Read full original descriptionShow less
Can symptom-provocation before tDCS improve therapeutic response in OCD patients ?
Researchers will compare the clinical outcomes of OCD patients having received, in one arm, tDCS and, in the other arm, patients having received tDCS preceded by symptom provocation to see if therapeutic response and various other clinical variables differ.
The 2 groups in the trial
- tDCSSham treatment, for comparison
These patients will only receive tDCS
Treatment: tDCS session
- tDCS + symptom provocationExisting treatment, for comparison
These patients will experience symptom provocation followed with tDCS
Treatment: tDCS session and symptom provocation
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Transcranial Direct Current Stimulation Associated With Symptom Provocation in the Management of Patients With Treatment-Resistant Obsessive-Compulsive Disorder.
- Fit questions
- Built from NCT07429500, who can take part
- Record updated
- 21 October 2026